SpaceOAR Vue (hydrogel)

2020: The announcement of SpaceOAR Vue - hydrogel for decrease in ghost effects at radiation therapy

In the middle of November, 2020 Boston Scientific produced medicine which should reduce ghost effects from beam radiation at patients with a prostate cancer. According to the press release, SpaceOAR Vue hydrogel is intended for creation of an additional layer between a prostate gland and a rectum during radiation therapy which protects healthy fabrics from radiation.

In randomized clinical trial in a check group in three years of therapy of the man noted decline in quality of life, the intestines tied with problems more often (41% in comparison with 14% in group of hydrogel) and urinations (30% in comparison with 17%). Men who used hydrogel could reach the erection sufficient for sexual intercourse also more often (66.7% in comparison with 37.5%).

SpaceOAR Vue hydrogel

Developers also note that hydrogel use also allows radiologists to use the computer tomography (CT) instead of the magnetic resonance imaging (MRI) as the gel layer improves visibility of circuits of tumoral structures on KT. Thanks to it doctors will be able to plan treatment without carrying out MRT that saves them from comparison and consolidation MRT-and KT-images of target area. The data obtained at KT should be enough for exact positioning of the patient at radiation therapy.

SpaceOAR Vue hydrogel is one more proof of how we respond to needs of doctors, helping them to give to patients the best care, - the senior vice president and the president of division of urology and diseases of bodies of a small pelvis of Boston Scientific noted Megane Scanlon (Meghan Scanlon). - Using SpaceOAR Vue hydrogel doctors will be able to optimize workflow, to create new plans of treatment using a computer tomography and by that will manage to reduce need of patients for post-procedural MRT.[1]

Notes